James R Neal Akari Therapeutics PLC (AKTX) insider trading activity
James R Neal is of Akari Therapeutics Plc. Currently has a direct ownership of 24.2 Million shares of AKTX, which is worth approximately $24.2 Million. The most recent transaction as insider was on Dec 23, 2024, when has been sold 2,000,000 shares (Ordinary shares, par value $0.0001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
24.2M
n/a
3M change
n/a
12M change
Total Value Held
$24.2 Million
James R Neal Transaction History
Also insider at
JRN
James R Neal
Emeryville, CA